AstraZeneca Says Vidal Memo Backs Case Against Fintiv Rule
AstraZeneca lawyers want a Virginia federal judge to give her take on a memo recently penned by U.S. Patent and Trademark Office Director Kathi Vidal that adjusted how patent board judges...To view the full article, register now.
Already a subscriber? Click here to view full article